RELEVANCE study: the R-squared regimen for follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 3:21 6 years ago 331 Далее Скачать
Follicular lymphoma: is RELEVANCE relevant? VJHemOnc – Video Journal of Hematology & HemOnc 6:38 6 years ago 251 Далее Скачать
Update on Follicular Lymphoma | LRF Webinars Lymphoma Research Foundation 59:58 1 year ago 3 461 Далее Скачать
RELEVANCE: Rituximab and lenalidomide in FL VJHemOnc – Video Journal of Hematology & HemOnc 1:03 2 years ago 613 Далее Скачать
How I approach early relapsing follicular lymphoma HMP Education 18:59 5 years ago 1 416 Далее Скачать
Overview of R2 Regimen for Relapsed Follicular Lymphoma Targeted Oncology 0:43 5 years ago 269 Далее Скачать
The RELEVANCE study: lenalidomide plus rituximab vs. rituximab-chemotherapy in the treatment of FL VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 194 Далее Скачать
Follicular Lymphoma Debate: Chemotherapy no Longer Has a Major Role in the Treatment HMP Education 22:46 4 years ago 5 237 Далее Скачать
Findings From the RELEVANCE Trial in Follicular Lymphoma Targeted Oncology 1:18 5 years ago 173 Далее Скачать
Results of RELEVANCE: frontline rituximab-lenalidomide for follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 3:52 6 years ago 820 Далее Скачать
Phase II study of acalabrutinib, lenalidomide & rituximab for high tumor burden follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 3:26 1 year ago 184 Далее Скачать
Treating advanced follicular lymphoma progressive or relapsed after R2 VJHemOnc – Video Journal of Hematology & HemOnc 3:40 3 years ago 726 Далее Скачать
Follicular Lymphoma Debate: Does Chemotherapy Have a Major Role to play? HMP Education 22:46 4 years ago 1 395 Далее Скачать
Tazemetostat in combination with lenalidomide and rituximab for R/R follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:48 1 year ago 207 Далее Скачать
